NCT04681456

Skin Cancer Oncology Radiation Evidence Registry

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 350 (actual)
• Sponsor: GenesisCare USA · Academic / Other
• Sex: All
• Age: 18 Years – 120 Years
• Healthy volunteers: Not accepted

Summary

To collect and analyze long term safety and efficacy outcomes of patients undergoing radiotherapy for non-melanoma skin cancer. A target of 400 VMAT-treated sites is set which is estimated to be identified in approximately 350 participants. Participants referred for radiotherapy for the management of non-melanoma skin cancer.

Detailed description

The Registry will collect information on key clinical indications and patient reported outcomes to assess the safety and efficacy of VMAT radiotherapy. Data that will be collected includes baseline data of demographic, relevant medical history, photographs, treatment schedule, and treatment outcomes. Data may be collected retrospectively in regard to previous relevant medical history, prior treatments and outcomes as well as prospectively, including treatment schedule and treatment outcomes of radiotherapy treatment. The Registry aims to assess the safety and outcomes of treatment for up to 5 years. This Registry will be the first of its kind in the US and will provide a basis for a number of potential research publications. The Registry will also give insights into treatment delivery and potentially facilitate future improvements in patient care.

Conditions

• Non-melanoma Skin Cancer

Interventions

Type	Name	Description
BEHAVIORAL	There is no medical intervention for the purposes of this Registry.	There is no medical intervention for the purposes of this Registry.

Timeline

• Start date: 2021-02-15
• Primary completion: 2021-05-06
• Completion: 2021-05-06
• First posted: 2020-12-23
• Last updated: 2021-05-14

Locations

1 site across 1 country: United States